Anticoccidial Drugs Market Size, Share & Industry Analysis, By Drug Class (Ionophores, Antibiotic, Sulphonamides, Amprolium, Others), By Animal Type (Livestock, Companion Animal), By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy) and Regional Forecast, 2024-2032

In April 2019, Creative Diagnostics developed anticoccidial drug analysis products to test residues for the anticoccidial drug in animals. This advancement and awareness of anticoccidial drugs will impact the anticoccidial drugs market trend. The rising awareness of animal health and zootonic diseases is anticipated to increase the adoption of anticoccidial drugs. The increasing meat-eating population and dependence on cattle products are projected to play a major driving factor for anticoccidial drugs market growth. Additionally, the rise in research and development for animal drugs have also expected to provide anticoccidial drugs growth opportunity.

The global anticoccidial drugs market growth is projected to be driven by the increased coccidian disease outbreak combined with the increasing dependency of poultry products. Additionally, stringent government regulation to maintain livestock health in developed countries is anticipated to increase the adoption of anticoccidial drugs. The increasing expenditure and veterinary health awareness among pet owners are expected to be an anticoccidial drug market driver.

Conversely, certain government guidelines that restrict the use of antimicrobial anticoccidial drugs in livestock is anticipated to restrain the anticoccidial drugs market growth. Additionally, the increasing demand for antibiotic-free meat has projected to impact the growing anticoccidial drugs market trend negatively.

Key Players Covered

Some of the major companies included in the global anticoccidial drugs market report are Zoetis, Bayer AG, Novartis AG, Virbac S.A, HIPRA, Elanco, Boehringer Ingelheim International GmbH, Virbac, and other players.

Segmentation

As per the current anticoccidial drugs market trends, livestock animal type segment is estimated to hold major market share owing to the increase in disease outbreak and increasing awareness of coccidia diseases among poultry owners.

Key Insights

• Regulatory Scenario – For Key Countries


• New Product Launch


• Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018

Regional Analysis

The global anticoccidial drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The developed countries of North America and Europe are estimated to dominate the global anticoccidial drugs market owing to established veterinary healthcare and active involvement of government in livestock health and management. The countries of Asia Pacific, Latin America, are anticipated to register a higher CAGR in the global anticoccidial drugs market growth owing to increased dependency on livestock and increasing pet owners. In the Middle East and Africa, the unmet need for veterinary health is expected to be an anticoccidial drugs market driver in the region.

Key Industry Developments

• In 2014, Zoetis announced the reintroduction of Zoamix, a synthetic anticoccidial drug indicated for poultry.


• In February 2015, Zoetis announced the completion of acquisition of animal health division of Abbott.


• In May 2016, Laboratorios Hipra received European Union approval for the company’s Evalon coccidiosis vaccine